Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Histogen Inc. - Common Stock (NQ:HSTO)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Histogen Inc. - Common Stock

Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
From Histogen Inc
Via GlobeNewswire
Histogen Announces Second Adjournment of Special Meeting of Stockholders
From Histogen Inc
Via GlobeNewswire
Histogen Announces Adjournment of Special Meeting of Stockholders
Meeting Adjourned to December 14, 2023 at 8:00 a.m. PT 
From Histogen Inc
Via GlobeNewswire
Positive Phase 1 Results in Covid-19 Patients for Histogen, Inc. (NASDAQ: HSTO)
Via Get News
Histogen Announces Board Approval of Complete Liquidation and Dissolution
From Histogen Inc
Via GlobeNewswire
Histogen to Explore Strategic Alternatives
From Histogen Inc
Via GlobeNewswire
Histogen Reports First Quarter 2023 Results and Provides Business Update
From Histogen Inc
Via GlobeNewswire
Histogen Announces Online Publication in the Journal of Investigative Dermatology
From Histogen Inc
Via GlobeNewswire
Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University
From Histogen Inc
Via GlobeNewswire
Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use
From Histogen Inc
Via GlobeNewswire
Histogen Reports Year-End 2022 Results and Provides Business Update
Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases 
From Histogen Inc
Via GlobeNewswire
Histogen Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Histogen Inc
Via GlobeNewswire
Histogen Hires Alfred P. Spada Ph.D. as Executive Vice President and Chief Scientific Officer
Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases 
From Histogen Inc
Via GlobeNewswire
Histogen Reports Third Quarter 2022 Financial Results and Provides Business Update
From Histogen Inc
Via GlobeNewswire
Histogen to Report Second Quarter 2022 Financial Results and Provide Business Update
From Histogen Inc
Via GlobeNewswire
Positive Phase 1 Results in Covid-19 Patients for Histogen, Inc. (NASDAQ: HSTO) Regenerative Medicine as well
Positive Phase 1 Results in Covid-19 Patients for Histogen, Inc. (NASDAQ: HSTO) Regenerative Medicine also 
Via EIN Presswire
Topics Intellectual Property
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.